3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
Recruiting now
Conditions studied: Cirrhosis, Liver, Portal Hypertension, Advanced Chronic Liver Disease
In brief
How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis or advanced chronic liver disease. We plan to investigate the ability of three demensional-magnetic resonance elastography (3D-MRE) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis or advanced chronic liver disease.
Key facts
- Study ID
- NCT05475015
- Run by
- Shengjing Hospital
- People needed
- 150
- Starts
- 2022-08-16
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-02-09
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Shengjing Hospital — Shenyang, Liaoning, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.